Cargando…
Predictors of mortality and treatment success of multi-drug resistant and Rifampicin resistant tuberculosis in Zimbabwe: a retrospective cohort analysis of patients initiated on treatment during 2010 to 2015
INTRODUCTION: Zimbabwe is one of the 30 countries globally with a high burden of multidrug-resistant TB or rifampicin-resistant TB. The World Health Organization recommended that patients diagnosed with multidrug-resistant TB be treated with 20-24 month standardized second-line drugs since 2010. How...
Autores principales: | Matambo, Ronnie, Nyandoro, George, Sandy, Charles, Nkomo, Tendai, Mutero-Munyati, Shungu, Mharakurwa, Sungano, Chikaka, Elliot, Ngwenya, Mkhokheli, Ndongwe, Gilchriste, Pepukai, Vongai Mildred |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The African Field Epidemiology Network
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8418161/ https://www.ncbi.nlm.nih.gov/pubmed/34527144 http://dx.doi.org/10.11604/pamj.2021.39.128.27726 |
Ejemplares similares
-
The role of bacteriological monitoring using culture and drug susceptibility tests (CDST) on treatment outcomes among MDR/RR-TB patients on treatment: a cohort analysis of patients enrolled on treatment 2010-2015 in Zimbabwe
por: Matambo, Ronnie, et al.
Publicado: (2021) -
Treatment outcomes of multi drug resistant and rifampicin resistant Tuberculosis in Zimbabwe: A cohort analysis of patients initiated on treatment during 2010 to 2015
por: Matambo, Ronnie, et al.
Publicado: (2020) -
Flexibility of deployment: challenges and policy options for retaining health workers during crisis in Zimbabwe
por: Mashange, Wilson, et al.
Publicado: (2019) -
The political economy of results-based financing: the experience of the health system in Zimbabwe
por: Witter, Sophie, et al.
Publicado: (2019) -
Results-based financing as a strategic purchasing intervention: some progress but much further to go in Zimbabwe?
por: Witter, Sophie, et al.
Publicado: (2020)